World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
15127
World Ranking
13013
National Ranking
5548

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibody
  • Gene
  • Immune system

His scientific interests lie mostly in Virology, Antibody, Neutralization, Virus and Epitope. His research brings together the fields of Protein structure and Virology. The study incorporates disciplines such as Lineage, Viral protein and Antigen in addition to Antibody.

M. Gordon Joyce has included themes like Molecular biology, Monoclonal antibody and Primary and secondary antibodies in his Neutralization study. The Virus study which covers Vaccination that intersects with Mutant. His study focuses on the intersection of Epitope and fields such as Immune system with connections in the field of Mutation.

His most cited work include:

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus (776 citations)
  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env (544 citations)
  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus (524 citations)

What are the main themes of his work throughout his whole career to date?

M. Gordon Joyce mainly focuses on Virology, Antibody, Virus, Epitope and Neutralization. M. Gordon Joyce works in the field of Virology, namely Vaccination. His studies in Antibody integrate themes in fields like Immune system and Glycan.

His study in Epitope is interdisciplinary in nature, drawing from both Hemagglutinin, Peptide sequence, Immunogen and Antigenicity. The various areas that M. Gordon Joyce examines in his Neutralization study include Molecular biology, CD4 antigen, Monoclonal antibody and Primary and secondary antibodies. He has researched Antigen in several fields, including Influenza A virus, Viral protein and Glycoprotein.

He most often published in these fields:

  • Virology (86.36%)
  • Antibody (77.27%)
  • Virus (37.88%)

What were the highlights of his more recent work (between 2018-2021)?

  • Virology (86.36%)
  • Virus (37.88%)
  • Antibody (77.27%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Virology, Virus, Antibody, B cell and Vaccination. His Virology research is multidisciplinary, incorporating elements of Epitope, Immunization, Antigen and Somatic hypermutation. His Epitope study combines topics in areas such as Viral Vaccine, Epstein–Barr virus, Antigenicity and Protein stabilization.

His Somatic hypermutation study incorporates themes from Hiv 1 vaccine, Neutralization, Memory B cell, Viral replication and Glycan. M. Gordon Joyce specializes in Virus, namely Hemagglutinin. His Hemagglutinin research incorporates elements of Viral entry, Virus-like particle and Binding site.

Between 2018 and 2021, his most popular works were:

  • Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. (78 citations)
  • Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. (78 citations)
  • Immunization With Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells (36 citations)

Best Publications

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

    Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

    Hadi M. Yassine;Jeffrey C. Boyington;Patrick M. McTamney;Patrick M. McTamney;Chih Jen Wei;Chih Jen Wei

  • Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G

    Guillaume B.E. Stewart-Jones;Cinque Soto;Thomas Lemmin;Thomas Lemmin;Gwo Yu Chuang

  • Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

    Joan O. Ngwuta;Man Chen;Kayvon Modjarrad;Kayvon Modjarrad;M. Gordon Joyce

  • Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

    Sung Youl Ko;Amarendra Pegu;Rebecca S. Rudicell;Zhi Yong Yang

  • Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies.

    Tongqing Zhou;Jiang Zhu;Xueling Wu;Stephanie Moquin

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

    Masaru Kanekiyo;Wei Bu;M. Gordon Joyce;Geng Meng

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

  • Evaluation of candidate vaccine approaches for MERS-CoV

    Lingshu Wang;Wei Shi;M. Gordon Joyce;Kayvon Modjarrad

  • Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

    Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  • Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

    Masaru Kanekiyo;M Gordon Joyce;M Gordon Joyce;Rebecca A Gillespie;John R Gallagher

  • Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

    Xueling Wu;Xueling Wu;Zhenhai Zhang;Chaim A. Schramm;M. Gordon Joyce

  • Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

    Ming Tian;Ming Tian;Cheng Cheng;Xuejun Chen;Hongying Duan

Frequent Co-Authors

Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
John R. Mascola
John R. Mascola ModeX Therapeutics
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Lawrence Shapiro
Lawrence Shapiro Columbia University
Yongping Yang
Yongping Yang National Institutes of Health
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Adrian B. McDermott
Adrian B. McDermott National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing M. Gordon Joyce

Trending Scientists